Mental Health Clinics in Weiser, ID Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Integrity Therapeutic Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 36 E Idaho St # 1, Weiser, ID 83672 Phone: 208-549-2163 Fax: 208-549-0806 |
Integrity Therapeutic Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 36 E Idaho St # 1, Weiser, ID 83672 Phone: 208-549-2163 Fax: 208-549-0806 |
Mellow Mountain Counseling Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 824 Mccormick Rd, Weiser, ID 83672 Phone: 208-248-0477 |
Pathways, Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 115 W Idaho St, Weiser, ID 83672 Phone: 208-878-3350 Fax: 208-878-3351 |
News Archive
Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas
The US, which has a mostly private health-care system, manages to spend more on its public health-care system than countries where the health-care system is almost entirely public. America's government spends more, as a percentage of the economy, on public health care than Canada, the United Kingdom, Japan or Australia. And then it spends even more than that on private health care.
Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox
Quantitative magnetic resonance imaging can detect microstructural changes in the spinal cords of patients with multiple sclerosis that correlate with observed differences in clinical disability, according to a cross-sectional study in Neurology.
Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine today announces a strategic collaboration with Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and a global leader in pulmonary arterial hypertension, to discover and validate a breath-based test to help facilitate the early diagnosis of pulmonary hypertension and its subtypes.
New AI method optimizes touchscreen interfaces for users with disabilities
Researchers at Aalto University, Finland, and Kochi University of Technology, Japan, developed a new algorithmic approach to user interface optimization that takes individual differences into account.
› Verified 1 days ago